CANHLIFE

Canara HSBC Life Insurance Company Share Price

 

 

Invest in Canara HSBC Life Insurance Company with 3.39X leverage

Invest with MTF

Performance

  • Low
  • ₹146
  • High
  • ₹154
  • 52 Week Low
  • ₹106
  • 52 Week High
  • ₹158
  • Open Price₹150
  • Previous Close₹150
  • Volume1,711,794
  • 50 DMA₹134.27
  • 100 DMA-
  • 200 DMA-

Investment Returns

  • Over 1 Month + 3.85%
  • Over 3 Month + 29.61%
  • Over 6 Month + 38.23%
  • Over 1 Year + 38.23%

Smart Investing Starts Here Start SIP with Canara HSBC Life Insurance Company for Steady Growth!

Invest Now

Canara HSBC Life Insurance Company Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 112.3
  • PEG Ratio
  • -
  • Market Cap Cr
  • 13,919
  • P/B Ratio
  • 9
  • Average True Range
  • 6.5
  • EPS
  • 1.3
  • Dividend Yield
  • 0
  • MACD Signal
  • 3.71
  • RSI
  • 57.51
  • MFI
  • 63.84

Canara HSBC Life Insurance Company Financials

Canara HSBC Life Insurance Company Technicals

EMA & SMA

Current Price
₹146.52
-3.17 (-2.12%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 11
  • 20 Day
  • ₹142.47
  • 50 Day
  • ₹134.27
  • 100 Day
  • -
  • 200 Day
  • -

Resistance and Support

148.61 Pivot Speed
  • R3 159.18
  • R2 156.35
  • R1 151.44
  • S1 143.70
  • S2 140.87
  • S3 135.96

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Canara HSBC Life Insurance Company Limited, a joint venture of Canara Bank, HSBC Insurance, and Punjab National Bank, offers a wide range of life, health, retirement, and group insurance products across India through bancassurance, digital, and direct distribution channels.

Canara Hsbc Life Ins Comp Ltd has an operating revenue of Rs. 15,906.90 Cr. on a trailing 12-month basis. An annual revenue de-growth of -9% needs improvement, Pre-tax margin of 1% needs improvement, ROE of 7% is fair but needs improvement. The stock from a technical standpoint is comfortably placed above its key moving averages, around 12% and 15% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 16% from the pivot point (which is extended from the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 61 which is a FAIR score but needs to improve its earnings, a RS Rating of 91 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at A which is evident from recent demand for the stock, Group Rank of 25 indicates it belongs to a strong industry group of Insurance-Life and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Canara HSBC Life Insurance Company Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-01-21 Quarterly Results & Others To consider other business matters.
2025-10-27 Quarterly Results

Canara HSBC Life Insurance Company F&O

Canara HSBC Life Insurance Company Shareholding Pattern

62%
17.35%
0.5%
4.57%
13%
2.15%
0.43%

About Canara HSBC Life Insurance Company

  • NSE Symbol
  • CANHLIFE
  • BSE Symbol
  • 544583
  • Managing Director & CEO
  • Mr. Anuj Dayal Mathur
  • ISIN
  • INE01TY01017

Similar Stocks to Canara HSBC Life Insurance Company

Canara HSBC Life Insurance Company FAQs

Canara HSBC Life Insurance Company share price is ₹146 As on 24 January, 2026 | 13:08

The Market Cap of Canara HSBC Life Insurance Company is ₹13919.4 Cr As on 24 January, 2026 | 13:08

The P/E ratio of Canara HSBC Life Insurance Company is 112.3 As on 24 January, 2026 | 13:08

The PB ratio of Canara HSBC Life Insurance Company is 9 As on 24 January, 2026 | 13:08

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23